Meridian Bioscience to Participate in the 2022 H. C. Wainwright Bioconnect Virtual Conference
CINCINNATI, Jan. 4, 2022 /PRNewswire/ — Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the 2022 H. C. Wainwright Bioconnect Virtual Conference. Jack Kenny, Chief Executive Officer, will pre-record a presentation that will be available on January 10, 2022. Webcast links to Meridian’s presentation will be available […]